157 related articles for article (PubMed ID: 800357)
1. The relevance of studies on androgen action to prostatic cancer.
Mainwaring WI
Curr Top Mol Endocrinol; 1976; 4():152-71. PubMed ID: 800357
[No Abstract] [Full Text] [Related]
2. A comparative study of binding, metabolism and endogenous levels of androgens in normal, hyperplastic and carcinomatous human prostate.
Krieg M; Bartsch W; Janssen W; Voigt KD
J Steroid Biochem; 1979 Jul; 11(1B):615-24. PubMed ID: 90754
[No Abstract] [Full Text] [Related]
3. The influence of androgen deprivation therapy on dihydrotestosterone levels in the prostatic tissue of patients with prostate cancer.
Nishiyama T; Hashimoto Y; Takahashi K
Clin Cancer Res; 2004 Nov; 10(21):7121-6. PubMed ID: 15534082
[TBL] [Abstract][Full Text] [Related]
4. Androgens and androgen-receptors in prostate tissue from patients with benign prostatic hyperplasia: effects of cyproterone acetate.
de Jong FH; Reuvers PJ; Bolt-de Vries J; Mulder E; Blom JH; Schroeder FH
J Steroid Biochem Mol Biol; 1992 Mar; 42(1):49-55. PubMed ID: 1373073
[TBL] [Abstract][Full Text] [Related]
5. Androgen binding and metabolism in the human prostate.
Attramadal A; Tveter KJ; Weddington SC; Djöseland O; Naess O; Hansson V; Torgersen O
Vitam Horm; 1975; 33():247-64. PubMed ID: 59460
[No Abstract] [Full Text] [Related]
6. Physiologic basis for hormonal theapy in carcinoma of the prostate.
Walsh PC
Urol Clin North Am; 1975 Feb; 2(1):125-40. PubMed ID: 48206
[No Abstract] [Full Text] [Related]
7. Androgens and prostate cancer: biology, pathology and hormonal therapy.
Galbraith SM; Duchesne GM
Eur J Cancer; 1997 Apr; 33(4):545-54. PubMed ID: 9274433
[No Abstract] [Full Text] [Related]
8. Quantification of androgen binding, androgen tissue levels, and sex hormone-binding globulin in prostate, muscle and plasma of patients with benign prostatic hypertrophy.
Krieg M; Bartsch W; Herzer S; Becker H; Voigt KD
Acta Endocrinol (Copenh); 1977 Sep; 86(1):200-15. PubMed ID: 71838
[No Abstract] [Full Text] [Related]
9. Modulation of AKR1C2 by curcumin decreases testosterone production in prostate cancer.
Ide H; Lu Y; Noguchi T; Muto S; Okada H; Kawato S; Horie S
Cancer Sci; 2018 Apr; 109(4):1230-1238. PubMed ID: 29369461
[TBL] [Abstract][Full Text] [Related]
10. Key targets of hormonal treatment of prostate cancer. Part 1: the androgen receptor and steroidogenic pathways.
Vis AN; Schröder FH
BJU Int; 2009 Aug; 104(4):438-48. PubMed ID: 19558559
[TBL] [Abstract][Full Text] [Related]
11. Androgen of the human prostate.
Farnsworth WE; Brown JR
Endocr Res Commun; 1976; 3(2):105-17. PubMed ID: 60232
[TBL] [Abstract][Full Text] [Related]
12. Prostate tissue androgens: history and current clinical relevance.
Marks LS; Mostaghel EA; Nelson PS
Urology; 2008 Aug; 72(2):247-54. PubMed ID: 18502483
[TBL] [Abstract][Full Text] [Related]
13. New concepts on the androgen sensitivity of prostate cancer.
Labrie F; Luthy I; Veilleux R; Simard J; Bélanger A; Dupont A
Prog Clin Biol Res; 1987; 243A():145-72. PubMed ID: 3309970
[No Abstract] [Full Text] [Related]
14. Biochemical endocrinology of prostatic tumors.
Voigt KD; Krieg M
Curr Top Exp Endocrinol; 1978; 3():173-99. PubMed ID: 77753
[No Abstract] [Full Text] [Related]
15. Androgen sensitivity of prostate epithelium is enhanced by postnatal androgen receptor inactivation.
Simanainen U; McNamara K; Gao YR; Handelsman DJ
Am J Physiol Endocrinol Metab; 2009 Jun; 296(6):E1335-43. PubMed ID: 19366880
[TBL] [Abstract][Full Text] [Related]
16. Estrogen signaling and disruption of androgen metabolism in acquired androgen-independence during cadmium carcinogenesis in human prostate epithelial cells.
Benbrahim-Tallaa L; Liu J; Webber MM; Waalkes MP
Prostate; 2007 Feb; 67(2):135-45. PubMed ID: 17075824
[TBL] [Abstract][Full Text] [Related]
17. Androgen metabolism in patients with benign prostatic hypertrophy.
Voigt KD; Horst HJ; Krieg M
Vitam Horm; 1975; 33():417-38. PubMed ID: 59462
[No Abstract] [Full Text] [Related]
18. Total androgen suppression in the management of prostatic cancer. A critical review.
Schroeder FH
Prog Clin Biol Res; 1985; 185A():307-17. PubMed ID: 3898133
[No Abstract] [Full Text] [Related]
19. Androgen receptors in benign and malignant prostatic tissue.
Lakey WH; Bruchovsky N; Callaway T; Comeau T; Lieskovsky G; Rennie P; Shnitka T; Wilkin P
Trans Am Assoc Genitourin Surg; 1979; 71():19-22. PubMed ID: 94714
[TBL] [Abstract][Full Text] [Related]
20. [Effects of antiandrogen TZP-4238 on the prostatic androgen receptor and prostatic androgen in rat].
Honma S; Suzuki K; Takezawa Y; Minato K; Fukabori Y; Yamanaka H
Nihon Naibunpi Gakkai Zasshi; 1994 Oct; 70(8):925-40. PubMed ID: 7528148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
